ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 158

Performance of Joint Ultrasonography in the Diagnosis of Suspected Acute Crystal Arthritis : Results of a Prospective Study of 112 Patients

Pascal Zufferey1, Isabelle Fabreguet1, Roxana Valcov1, Alexandre Dumusc1 and Alexander K. So Sr.2, 1DAL, RHU/CHUV, Lausanne, Switzerland, 2Dal/Rhu, CHUV, Lausanne, Switzerland

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Chondrocalcinosis, Diagnostic Tests, gout, performance and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Title: Metabolic and Crystal Arthropathies: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose

The gold standard for diagnosing gout and CCP arthritis is the identification of monosodium urate (MSU) crystals in joint fluid. Ultrasound (US) features of gouty and CPP arthritis have been described (1,2), and the technique has been proposed as a diagnostic tool in acute arthritis. There have been limited studies on the performance of this technique as a diagnostic tool when applied to the setting of acute arthritis

The primary objective was to determine the performance of ultrasound as a diagnostic tool for CCPD and urate acute crystal arthritis, using crystal identification by microscopy as a gold standard.

Methods

117 consecutive patients who presented an acute arthritis of <10 days duration of suspected microcrystalline origin between October 2012 and January 2014 were prospectively included in the study. Aspiration of the symptomatic joint was performed and crystals identified by polarizing light microscopy. All patients underwent an US of the symptomatic joint as well as both knees, ankles and 1stMTP joints that was performed by a rheumatologist who was “blinded” to the clinical history within 24 hours of joint aspiration. An “US diagnosis” was made based of the findings in the symptomatic joint as well as the other joints examined by US.

Results

In 112 patients joint fluid was obtained. 53 had MSU, 27 CCPD and 9 had both crystals. No crystals were detected in 23. US signs of gout , CCP or mixed crystal  deposition were found in symptomatic joints of 40/38/7 patients respectively, and by multiple joints US, in 68/59/16  patients.

Table1 describes the sensitivity, the specificity, and the positive predictive value (PPV) and negative predictive values (NPV)

 

Gout

US Symptomatic joint

Gout

US Multiple joints

CCP

US symptomatic joint

CCP

US multiple joints

Sensitivity : %

60

84

60

81

Specificity %

92

76

80

62

PPV%

92

82

60

52

NPV%

62

77

80

87

The sensitivity of US signs in the symptomatic joint for both gout and CCP is poor. US is more specific for the diagnosis of gout that CCP arthritis (PPV>90% against 60%).

By US of multiple joints, the sensitivity of US for both diagnoses rose significantly but the specificity and the PPV decreased, especially for CCP (PPV52%). In absence of US signs in all the joints, CCP arthritis is highly unlikely (NPV 87%).

Conclusion

In patients with a clinical suspicion of acute microcrystalline arthritis, US examination may be of assistance in the diagnosis if joint aspiration is not feasible. The examination of multiple joints is required to obtain the best clinical utility


Disclosure:

P. Zufferey,
None;

I. Fabreguet,
None;

R. Valcov,
None;

A. Dumusc,
None;

A. K. So Sr.,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/performance-of-joint-ultrasonography-in-the-diagnosis-of-suspected-acute-crystal-arthritis-results-of-a-prospective-study-of-112-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology